Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
09:00-10:15
  • Symposium 1: 
    Evolving Treatment Strategies for ER+/HER2- Breast Cancer
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Chanheun Park
     (Kangbuk Samsung Hospital, Korea)
  • Komal Jhaveri
     (Memorial Sloan Kettering Cancer Center, U.S.A.)
Speakers
  • Upfront Surgery vs. Neoadjuvant Systemic Therapy to Optimize Locoregional Management in ER+/HER2- Breast Cancer
    Wonshik Han
     (Seoul National Univ. Hospital, Korea)
  • Beyond Endocrine Therapy for High-risk Early ER+/HER2- Breast Cancer After Neoadjuvant Chemotherapy
    Masakazu Toi
     (Kyoto Univ. Hospital, Japan)
  • Various Targeted Therapies for Advanced ER+/HER- Breast Cancer: To Whom Should We Give Which?
    Komal Jhaveri
     (Memorial Sloan Kettering Cancer Center, U.S.A.)
  • Panel Discussion 1: 
    Challenges of Artificial Intelligence(AI) in Fields of Breast Cancer Care
  • Venue:  RM 2(Vista 3)
Moderators
  • Min Jung Kim
     (Yonsei Univ. College of Medicine, Korea)
  • Heang-Ping Chan
     (Univ. of Michigan, U.S.A.)
Speakers
  • AI Meets Surgeon, Where Are We and How to Use?
    Beomseok Ko
     (ASAN Medical Center, Korea)
  • Application of AI-based Breast Imaging and Diagnosis
    Heang-Ping Chan
     (Univ. of Michigan, U.S.A.)
  • The Use of AI for Personalized Radiation Therapy
    Bum-Sup Jang
     (Seoul National Univ. Hospital, Korea)
  • Education Session 1: 
    Breast Cancer Screening in the Era of Precision Medicine
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Eun-Kyung Kim
     (Yongin Severance Hospital, Korea)
  • Christopher E. Comstock
     (Memorial Sloan Kettering Cancer Center, U.S.A.)
Speakers
  • Implementing Risk Assessment in the Routine Practice
    Su Hyun Lee
     (Seoul National Univ. Hospital, Korea)
  • Novel Paradigms for Tailored Screening including Contrast Mammography and MRI
    Christopher E. Comstock
     (Memorial Sloan Kettering Cancer Center, U.S.A.)
  • AI in Screening and Diagnostic Breast Imaging
    Jung Hyun Yoon
     (Severance Hospital, Korea)
  • Oral Presentation 1
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Gyungyub Gong
     (ASAN Medical Center, Korea)
  • Seung Ki Kim
     (CHA Bundang Medical Center, Korea)
  • GBCC-JBCS Joint Session 1: 
    Joint Clinical Trials for De-escalation and Escalation of Locoregional Treatment of Breast Cancer
  • Venue:  RM 5(Art Hall)
Moderators
  • Jong Han Yu
     (Samsung Medical Center, Korea)
  • Hiroji Iwata
     (Aichi Cancer Center Hospital, Japan)
Speakers
  • Omission of Surgery for Pathologic Complete Response Diagnosed with MRI and BIopsy in Breast Cancer After Neoadjuvant Chemotherapy: OPTIMIST Trial
    Han-Byoel Lee
     (Seoul National Univ. Hospital, Korea)
  • Trials of Surgery in Japan
    Hideo Shigematsu
     (National Hospital Organization Kure Medical Center and Chugoku Cancer Center , Japan)
  • Impact of Post-mastectomy Radiotherapy in Breast Cancer Patients with Excellent Response After Neoadjuvant Chemotherapy: A Phase 3, Multicenter, Randomized, Non-inferiority Study
    Soong June Bae
     (Gangnam Severance Hospital, Korea)
  • Trials of Radiation Therapy in Japan
    Chikako Yamauchi
     (Shiga General Hospital, Japan)
10:30-11:45
  • Symposium 2: 
    Novel Breakthrough in the Treatment of HER2+ Breast Cancer
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Kyong Hwa Park
     (Korea Univ. Anam Hospital, Korea)
  • Yoon-Sim Yap
     (National Cancer Centre Singapore, Singapore)
Speakers
  • Antibody-Drug Conjugates and Engineered Antibodies
    Yoon-Sim Yap
     (National Cancer Centre Singapore, Singapore)
  • HER2 Targeted TKI: Overview and Overcoming Resistance
    Shaheenah Dawood
     (Mediclinic City Hospital, U.A.E.)
  • A New Promise: HER2 Vaccines and Immunotherapy
    Kyong Hwa Park
     (Korea Univ. Anam Hospital, Korea)
  • Panel Discussion 2: 
    Nationwide Big Data for Clinical Research in Breast Cancer
  • Venue:  RM 2(Vista 3)
Moderators
  • Dong-Young Noh
     (CHA Medical Center, Korea)
  • Mehra Golshan
     (Yale School of Medicine, U.S.A.)
Speakers
  • Leveraging Large Data Bases (SEER/NCDB) to Create Scientific Rigor for Clinical Trials in Breast Cancer
    Mehra Golshan
     (Yale School of Medicine, U.S.A.)
  • Breast Cancer Research Using National Health Insurance Database in Korea
    Jihyoun Lee
     (Soonchunhyang Univ. Hospital Seoul, Korea)
  • Clinicopathological Characteristics of Male Breast Cancer in Japan from the National Clinical Database
    Akihiko Shimomura
     (National Center for Global Health and Medicine, Japan)
  • Education Session 2: 
    Less Toxic Breast Radiotherapy
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Shu-Lian Wang
     (Chinese Academy of Medical Sciences, China)
  • Su Ssan Kim
     (ASAN Medical Center, Korea)
Speakers
  • Partial Breast Irradiation: A Beginner's Guide
    Ji Hyun Chang
     (Seoul National Univ. Hospital, Korea)
  • Heart Sparing RT: A Practical Consideration
    Shu-Lian Wang
     (Chinese Academy of Medical Sciences, China)
  • Advanced Techniques in Breast RT: from IMRT to Particle Therapy
    Rachel Jimenez
     (Massachusetts General Hospital, U.S.A.)
  • Oral Presentation 2
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Yoo Seok Kim
     (Chosun Univ. Hospital, Korea)
  • Okhee Woo
     (Korea Univ. Guro Hospital , Korea)
  • GBCC-JBCS Joint Session 2: 
    Joint Clinical Trials for De-escalation and Escalation of Systemic Treatment of Breast Cancer
  • Venue:  RM 5(Art Hall)
Moderators
  • Jee Hyun Kim
     (Seoul National Univ. Bundang Hospital, Korea)
  • Shigehira Saji
     (Fukushima Medical Univ., Japan)
Speakers
  • Randomized, Phase II Trial to Evaluate the Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy Compared to Capecitabine Monotherapy for Triple Receptor-Negative Breast Cancer with Residual Invasive Cancer after Neoadjuvant Chemotherapy (MIRINAE trial, KCSG-BR18-21)
    In Hae Park
     (Korea Univ. Guro Hospital, Korea)
  • Trials of ER(+) Cancer in Japan
    Toshimi Takano
     (The Cancer Institute Hospital of JFCR, Japan)
  • Ovarian Function Suppression in Premenopausal Women with Node Positive Disease and Low Genomic Risk: OPAL Trial
    Tae-Kyung Robyn Yoo
     (ASAN Medical Center, Korea)
  • Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy in Older Patients: RESPECT Trial
    Masataka Sawaki
     (Aichi Cancer Center Hospital, Japan)
12:00-12:45
  • Plenary Lecture 1
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Seock-Ah Im
     (Seoul National Univ. Hospital, Korea)
Speakers
  • Targeting Homologous Recombination Deficient Breast Cancer: Moving from Advanced to Early Disease
    Andrew Tutt
     (Institute of Cancer Research, King’s College London, UK)
13:00-13:45
  • Satellite Symposium 1: 
    Pfizer Korea
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Sang Seol Jung
     (Kyung Hee Univ. Medical Center, Korea)
Speakers
  • Maximizing Clinical Outcome in HR+HER2- Metastatic Breast Cancer Patients: Palbociclib & CDK4/6 Inhibitors in Real-world Practice
    Kyong Hwa Park
     (Korea Univ. Anam Hospital, Korea)
14:00-14:45
  • Plenary Lecture 2
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Yeon Hee Park
     (Samsung Medical Center, Korea)
Speakers
  • Harnessing the Value Afforded by Whole Genome Sequencing of Breast Cancers
    Serena Nik-Zainal
     (Univ. of Cambridge, UK)
15:00-16:15
  • Panel Discussion 3: 
    Fertility Preservation for Younger Breast Cancer Patients
  • Venue:  RM 2(Vista 3)
Moderators
  • Woochul Noh
     (Konkuk Univ. Medical Center, Korea)
  • Matteo Lambertini
     (IRCCS Policlinico San Martino Hospital - Univ. of Genova, Italy)
Speakers
  • How I Perform Fertility Preservation in Breast Cancer Patients
    Matteo Lambertini
     (IRCCS Policlinico San Martino Hospital - Univ. of Genova, Italy)
  • Onco-fertility Modules and Conseling in Young Women with Breast Cancer: Asian Experience
    Heejeong Kim
     (ASAN Medical Center, Korea)
  • Shared Decision Making for Fertility Preservation
    Ling-Ming Tseng
     (Taipei Veterans General Hospital, Taiwan)
  • Education Session 3: 
    Optimal Therapy for Women with Early Breast Cancer
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Bora Lim
     (Baylor College of Medicine, U.S.A.)
  • Joohyuk Sohn
     (Yonsei Cancer Center, Korea)
Speakers
  • Neoadjuvant and Adjuvant Treatment for Triple Negative Breast Cancer
    Bora Lim
     (Baylor College of Medicine, U.S.A.)
  • Neoadjuvant and Adjuvant Treatment for HER2-positive Breast Cancer
    Joohyuk Sohn
     (Yonsei Cancer Center, Korea)
  • Use of Multigene Assay in HR+HER2- Breast Cancer
    Tom Wei-Wu Chen
     (National Taiwan Univ. Hospital, Taiwan)
  • Endoscopic and Robotic Breast Surgery Session: 
    Recent Updates for Endoscopic and Robotic Breast Surgery
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Hyukjai Shin
     (Myongji Hospital, Korea)
  • Hyung Seok Park
     (Severance Hospital, Korea)
Speakers
  • Benefits and Drawbacks: Multi-port Robotic Mastectomy
    Hung-Wen Lai
     (Changhua Christian Hospital, Taiwan)
  • Benefits and Drawbacks: Single-port Robotic Mastectomy
    Hyung Seok Park
     (Severance Hospital, Korea)
  • Recent Updates for Endoscopic Mastectomy with Axillary Surgery
    Chi Wei Mok
     (Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)
  • Endoscopic/Robotic-assisted Harvest of Latissimus Dorsi Flap for Partial Breast Reconstruction
    Jung Dug Yang
     (Kyungpook National Univ. Chilgok Hospital, Korea)
  • GBCC Sino-Korean Joint Session: 
    Taking Actions Against Increasing Asian Breast Cancer Burden
  • Venue:  RM 5(Art Hall)
Moderators
  • Il Yong Chung
     (ASAN Medical Center, Korea)
  • Peng Yuan
     (Chinese Academy of Medical Sciences, Cancer Hospital , China)
Speakers
  • Current Status and Future Strategy for Sporadic and Hereditary Breast Cancer in Asia
    Sang Yull Kang
     (Jeonbuk National Univ. Hospital, Korea)
  • Optimal Management for Chinese Women with Hereditary Breast Cancer
    Yuntao Xie
     (Peking Univ. Cancer Hospital, China)
Panelist
  • Collaborative Action Plans Against Asian Breast Cancer
    Sue Kyung Park
     (Seoul National Univ. College of Medicine, Korea)
  • Sang Ah Han
     (Kyung Hee Univ. Hospital at Gangdong, Korea)
  • Ying Fan
     (National Cancer Center, China)
  • Hongyan Zhang
     (The Third Medical Center of PLA General Hospital, China)
16:30-17:45
  • Panel Discussion 4: 
    Geriatric Oncology for Elderly Breast Cancer Patients
  • Venue:  RM 2(Vista 3)
Moderators
  • In Sook Woo
     (The Catholic Univ. of Korea, Yeouido St. Mary's Hospital, Korea)
  • Icro Meattini
     (Univ. of Florence, Italy)
Speakers
  • Is It safe to Omit Radiotherapy After Breast Conserving Surgery in Elderly Patients?
    Icro Meattini
     (Univ. of Florence, Italy)
  • Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Multiple Comorbidities
    Akimitsu Yamada
     (Yokohama City Univ. Hospital, Japan)
  • Prediction of Severe Toxicity in Older Adults Receiving Chemotherapy for Early-stage Breast Cancer
    In Sook Woo
     (The Catholic Univ. of Korea, Yeouido St. Mary's Hospital, Korea)
  • Education Session 4: 
    Consideration of Particular Type of Breast Neoplasm
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Tae Hyun Kim
     (Inje Univ. Busan Paik Hospital, Korea)
  • Sunil Lakhani
     (Univ. of QLD and Pathology QLD, Australia)
Speakers
  • Update on Management of Phyllodes Tumors of the Breast
    Jeong Eun Kim
     (ASAN Medical Center, Korea)
  • Overview of Metaplastic Breast Cancer
    Sunil Lakhani
     (Univ. of QLD and Pathology QLD, Australia)
  • Recent Updates in Pathology of LCIS, ALH, and ADH
    Aeree Kim
     (Korea Univ. Guro Hospital, Korea)
  • OPBS Session: 
    Future Perspectives in Oncoplastic Breast Surgery: From Personal to Professional
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Ho Yong Park
     (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Eun Sook Lee
     (National Cancer Center, Korea)
Speakers
  • Training the Oncoplastic Breast Surgeon: An International Perspective
    Patricia Lynn Clark
     (Ironwood Cancer and Research Centers, U.S.A.)
  • Evidence Reviews of Oncoplastic Breast Surgery
    Visnu Lohsiriwat
     (Siriraj Hospital, Mahidol Univ., Thailand)
  • Overcoming Hurdles in Oncoplastic Breast Surgery
    Jeeyeon Lee
     (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Plastic Surgeon's Perspective for Better Reconstruction Outcomes
    Ung Sik Jin
     (Seoul National Univ. Hospital, Korea)
  • GBCC-TBCS Joint Session: 
    Continuous Development and Networking Between Young Doctors in Two Countries
  • Venue:  RM 5(Art Hall)
Moderators
  • Jeong Eon Lee
     (Samsung Medical Center, Korea)
  • Yen-Shen Lu
     (National Taiwan Univ. Hospital, Taiwan)
Speakers
  • Education and Developmental Program for Young Doctors in Korea
    Soo Kyung Ahn
     (Hallym Univ. Kangnam Sacred Heart Hospital, Korea)
  • Education and Developmental Program for Young Doctors in Taiwan
    Yen-Shen Lu
     (National Taiwan Univ. Hospital, Taiwan)
Panelist
  • Continuous Networking Between Young Doctors in Two Countries
    Wei-Pang Chung
     (National Cheng Kung Univ. Hospital, Taiwan)
  • Yi-Fang Tsai
     (Taipei Veterans General Hospital, Taiwan)
  • Jun-Won Min
     (Dankook Univ. Hospital, Korea)
  • Hyun Yul Kim
     (Pusan National Univ. Yangsan Hospital, Korea)





Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP